Financial Statements — RVSN
Balance Sheet
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 |
|---|
| Cash & Equivalents | 22.43 | 9.69 | 8.19 | 12.93 |
| Accounts Receivable | 0.10 | 0.14 | 0.12 | 0.09 |
| Inventory | 1.43 | 0.97 | 0.49 | -- |
| Total Current Assets | 24.68 | 11.36 | 9.32 | 13.96 |
| Property, Plant & Equipment | 0.26 | 0.35 | -- | -- |
| Intangible Assets | -- | -- | 0.51 | 0.49 |
| Total Non-current Assets | 0.69 | 1.09 | 1.51 | 1.79 |
| Total Assets | 25.37 | 12.45 | 10.83 | 15.74 |
| Total Current Liabilities | 2.62 | 2.19 | 2.21 | 1.52 |
| Total Non-current Liabilities* | 0.06 | 0.36 | 0.63 | 0.95 |
| Total Liabilities | 2.68 | 2.56 | 2.84 | 2.47 |
| Retained Earnings | (102.35) | (90.29) | (60.65) | (49.59) |
| Total Stockholder Equity | 22.69 | 9.90 | 7.99 | 13.28 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 |
|---|
| Total Revenue | 0.24 | 0.76 | 0.22 | -- |
| Cost of Revenue | 0.19 | 0.14 | -- | 0.11 |
| Gross Profit | 0.05 | 0.39 | -- | 0.30 |
| Research & Development | 3.24 | 2.46 | 1.84 | 1.68 |
| Selling, General & Admin | 2.51 | 2.12 | 1.13 | 1.32 |
| Total Operating Expenses | 5.75 | 4.57 | -- | 2.59 |
| Operating Income | (5.70) | (4.18) | (2.96) | (3.00) |
| Net Income | (5.68) | (24.32) | (2.95) | (2.90) |
| Basic EPS | (0.11) | (1.99) | (0.16) | (0.19) |
| Diluted EPS | (0.11) | (1.99) | (0.16) | (0.19) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 |
|---|
| Operating Cash Flow | (4.66) | (4.59) | (5.41) | (3.25) |
| Capital Expenditures | 0.01 | 0.01 | 140.00 | 0.02 |
| Free Cash Flow* | (4.67) | (4.60) | (145.41) | (3.27) |
| Investing Cash Flow | (0.01) | (0.01) | (0.14) | (0.01) |
| Financing Cash Flow | 9.76 | 11.27 | 5.46 | 13.99 |
* Derived from reported values
